tradingkey.logo

Analysts start coverage on Medline with bullish ratings

ReutersJan 12, 2026 9:49 AM

At least six brokerages start coverage on medical supplies maker and distributor Medline MDLN.O with bullish ratings as industry-mandated quiet period ends

Medline made its public-market debut in December, valuing co at $46 billion in the largest U.S. IPO since Rivian's RIVN.O 2021 listing

JPM says MDLN’s recent market share gains are likely to endure, with co well-placed to keep winning business by offering cost savings alongside strong service

Jefferies says co is expected to grow at high single‑digit pace or better, with growth split evenly between existing customers and new client wins

Trading price of $40.52 as of Friday's close is higher than IPO price of $29

Ratings and PTs on the stock:

Brokerage

Rating

PT

J.P. Morgan

Overweight

$50

Leerink Partners

Outperform

$48

Baird

Outperform

$48

RBC

Outperform

$47

Piper Sandler

Overweight

$50

Jefferies

Buy

$50

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI